annual EBIT:
-$279.30M-$65.24M(-30.48%)Summary
- As of today (September 10, 2025), XENE annual earnings before interest & taxes is -$279.30 million, with the most recent change of -$65.24 million (-30.48%) on December 31, 2024.
- During the last 3 years, XENE annual EBIT has fallen by -$200.31 million (-253.57%).
- XENE annual EBIT is now -2409.01% below its all-time high of $12.10 million, reached on December 31, 2013.
Performance
XENE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$94.23M-$21.49M(-29.55%)Summary
- As of today (September 10, 2025), XENE quarterly earnings before interest & taxes is -$94.23 million, with the most recent change of -$21.49 million (-29.55%) on June 1, 2025.
- Over the past year, XENE quarterly EBIT has dropped by -$25.13 million (-36.36%).
- XENE quarterly EBIT is now -1187.97% below its all-time high of $8.66 million, reached on September 30, 2014.
Performance
XENE quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$318.12M-$25.13M(-8.58%)Summary
- As of today (September 10, 2025), XENE TTM earnings before interest & taxes is -$318.12 million, with the most recent change of -$25.13 million (-8.58%) on June 1, 2025.
- Over the past year, XENE TTM EBIT has dropped by -$80.60 million (-33.93%).
- XENE TTM EBIT is now -3758.23% below its all-time high of $8.70 million, reached on December 31, 2014.
Performance
XENE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XENE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.5% | -36.4% | -33.9% |
| 3 y3 years | -253.6% | -210.8% | -261.0% |
| 5 y5 years | -595.0% | -10000.0% | -988.4% |
XENE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -253.6% | at low | -210.8% | at low | -261.0% | at low |
| 5 y | 5-year | -876.2% | at low | <-9999.0% | at low | -988.4% | at low |
| alltime | all time | -2409.0% | at low | -1188.0% | at low | -3758.2% | at low |
XENE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$94.23M(+29.5%) | -$318.12M(+8.6%) |
| Mar 2025 | - | -$72.74M(-6.1%) | -$293.00M(+4.9%) |
| Dec 2024 | -$279.30M(+30.5%) | -$77.48M(+5.2%) | -$279.30M(+9.3%) |
| Sep 2024 | - | -$73.68M(+6.6%) | -$255.52M(+7.6%) |
| Jun 2024 | - | -$69.10M(+17.0%) | -$237.52M(+6.0%) |
| Mar 2024 | - | -$59.04M(+10.0%) | -$224.04M(+4.7%) |
| Dec 2023 | -$214.05M(+65.7%) | -$53.70M(-3.6%) | -$214.05M(+5.1%) |
| Sep 2023 | - | -$55.68M(+0.1%) | -$203.69M(+9.4%) |
| Jun 2023 | - | -$55.62M(+13.4%) | -$186.13M(+15.7%) |
| Mar 2023 | - | -$49.05M(+13.2%) | -$160.82M(+24.5%) |
| Dec 2022 | -$129.14M(+63.5%) | -$43.33M(+13.6%) | -$129.14M(+16.7%) |
| Sep 2022 | - | -$38.13M(+25.8%) | -$110.65M(+25.6%) |
| Jun 2022 | - | -$30.32M(+74.5%) | -$88.12M(+9.7%) |
| Mar 2022 | - | -$17.37M(-30.1%) | -$80.30M(+1.7%) |
| Dec 2021 | -$78.99M(+176.1%) | -$24.84M(+59.2%) | -$78.99M(+17.8%) |
| Sep 2021 | - | -$15.60M(-30.7%) | -$67.08M(+9.6%) |
| Jun 2021 | - | -$22.50M(+40.1%) | -$61.18M(+55.6%) |
| Mar 2021 | - | -$16.06M(+24.3%) | -$39.33M(+25.6%) |
| Dec 2020 | -$28.61M(-28.8%) | -$12.92M(+33.2%) | -$31.30M(+4.4%) |
| Sep 2020 | - | -$9.70M(+1401.4%) | -$29.98M(+2.6%) |
| Jun 2020 | - | -$646.00K(-92.0%) | -$29.23M(-25.2%) |
| Mar 2020 | - | -$8.03M(-30.7%) | -$39.09M(-8.7%) |
| Dec 2019 | -$40.18M(+21.3%) | -$11.60M(+29.6%) | -$42.82M(+8.0%) |
| Sep 2019 | - | -$8.95M(-14.8%) | -$39.66M(+2.0%) |
| Jun 2019 | - | -$10.51M(-10.6%) | -$38.88M(+8.1%) |
| Mar 2019 | - | -$11.76M(+39.4%) | -$35.96M(+12.3%) |
| Dec 2018 | -$33.13M(+7.9%) | -$8.43M(+3.1%) | -$32.00M(+1.2%) |
| Sep 2018 | - | -$8.18M(+7.8%) | -$31.62M(-1.5%) |
| Jun 2018 | - | -$7.59M(-2.8%) | -$32.09M(-0.9%) |
| Mar 2018 | - | -$7.81M(-3.0%) | -$32.39M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$30.70M(+23.7%) | -$8.05M(-6.9%) | -$32.58M(+8.6%) |
| Sep 2017 | - | -$8.64M(+9.5%) | -$29.99M(+4.6%) |
| Jun 2017 | - | -$7.89M(-1.2%) | -$28.67M(+5.6%) |
| Mar 2017 | - | -$7.99M(+46.2%) | -$27.15M(+9.4%) |
| Dec 2016 | -$24.82M(+165.1%) | -$5.46M(-25.5%) | -$24.82M(+13.0%) |
| Sep 2016 | - | -$7.33M(+15.2%) | -$21.96M(+42.2%) |
| Jun 2016 | - | -$6.37M(+12.5%) | -$15.45M(+73.9%) |
| Mar 2016 | - | -$5.66M(+117.4%) | -$8.88M(+100.5%) |
| Dec 2015 | -$9.36M(-184.3%) | -$2.60M(+217.4%) | -$4.43M(+147.2%) |
| Sep 2015 | - | -$820.00K(-512.1%) | -$1.79M(-123.3%) |
| Jun 2015 | - | $199.00K(-116.5%) | $7.69M(+2.7%) |
| Mar 2015 | - | -$1.21M(-3545.7%) | $7.49M(-13.9%) |
| Dec 2014 | $11.11M(-8.2%) | $35.00K(-99.6%) | $8.70M(+0.4%) |
| Sep 2014 | - | $8.66M(>+9900.0%) | $8.66M(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | $12.10M(-387.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | -$4.21M(-64.6%) | - | - |
| Dec 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | -$11.90M | - | - |
| Dec 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00 | $0.00 |
FAQ
- What is Xenon Pharmaceuticals Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual EBIT year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly EBIT year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM EBIT year-on-year change?
What is Xenon Pharmaceuticals Inc. annual earnings before interest & taxes?
The current annual EBIT of XENE is -$279.30M
What is the all time high annual EBIT for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual earnings before interest & taxes is $12.10M
What is Xenon Pharmaceuticals Inc. annual EBIT year-on-year change?
Over the past year, XENE annual earnings before interest & taxes has changed by -$65.24M (-30.48%)
What is Xenon Pharmaceuticals Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of XENE is -$94.23M
What is the all time high quarterly EBIT for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly earnings before interest & taxes is $8.66M
What is Xenon Pharmaceuticals Inc. quarterly EBIT year-on-year change?
Over the past year, XENE quarterly earnings before interest & taxes has changed by -$25.13M (-36.36%)
What is Xenon Pharmaceuticals Inc. TTM earnings before interest & taxes?
The current TTM EBIT of XENE is -$318.12M
What is the all time high TTM EBIT for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM earnings before interest & taxes is $8.70M
What is Xenon Pharmaceuticals Inc. TTM EBIT year-on-year change?
Over the past year, XENE TTM earnings before interest & taxes has changed by -$80.60M (-33.93%)